Cingulate Inc.
Cingulate Inc. (CING) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · CING · as of Jun 9, 2026
Activity summary
Buy transactions
8
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
∞
Buy/Sell (by trades)
Overall sentiment
Cingulate Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
CING insider buying and selling by quarter
CING insider selling · CING insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · CING ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
CING executive sell shares · CING board member insider trading · CING insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Feb 13, 2026 | Hargroves Thomas Jeffrey Director | Purchase | 97,276 | $490K | Form 4 |
| Mar 9, 2026 | Silva Raul R. EVP and CSO | Award | 4,526 | — | Form 4 |
| Mar 9, 2026 | Silva Raul R. EVP and CSO | Other | 1,828 | — | Form 4 |
| Mar 9, 2026 | Schaffer Shane J. CEO · Director | Award | 6,862 | — | Form 4 |
| Mar 9, 2026 | Schaffer Shane J. CEO · Director | Other | 2,959 | — | Form 4 |
| Mar 9, 2026 | Callahan Jennifer L. EVP and CFO | Award | 15,329 | — | Form 4 |
| Mar 9, 2026 | Callahan Jennifer L. EVP and CFO | Other | 6,427 | — | Form 4 |
| Mar 9, 2026 | Patel Nilay Dahyabhai EVP, CLO and CCO | Award | 5,475 | — | Form 4 |
| Mar 9, 2026 | Patel Nilay Dahyabhai EVP, CLO and CCO | Other | 2,086 | — | Form 4 |
| Mar 9, 2026 | Brams Matthew EVP and Chief Medical Officer | Award | 4,526 | — | Form 4 |
| Mar 9, 2026 | Brams Matthew EVP and Chief Medical Officer | Other | 1,025 | — | Form 4 |
| Feb 6, 2026 | Werth Peter J. Director | Purchase | 19,455 | $98K | Form 4 |
| Feb 6, 2026 | Callahan Jennifer L. SVP and CFO | Purchase | 4,864 | $25K | Form 4 |
| Feb 6, 2026 | Schaffer Shane J. CEO · Director | Purchase | 6,809 | $34K | Form 4 |
| Feb 6, 2026 | Brams Matthew EVP and Chief Medical Officer | Purchase | 1,946 | $10K | Form 4 |
| Aug 15, 2024 | Myers Laurie EVP and COO | Sale | 202 | $841 | Form 4 |
| Apr 11, 2024 | Werth Peter J. Director | Option | 694,096 | $69 | Form 4 |
| Apr 11, 2024 | Werth Peter J. Director | Option | 341,912 | $684 | Form 4 |
| Mar 15, 2022 | Callahan Jennifer L. SVP and CFO | Purchase | 55 | $1K | Form 4 |
| Sep 15, 2023 | Callahan Jennifer L. Corporate Controller | Purchase | 5,000 | $3K | Form 4 |
Hargroves Thomas Jeffrey
Director
Date
Feb 13
Shares
97,276
Price
$5.04
Value
$490K
Brams Matthew
EVP and Chief Medical Officer
Date
Mar 9
Shares
4,526
Price
—
Value
—
Brams Matthew
EVP and Chief Medical Officer
Date
Mar 9
Shares
1,025
Price
—
Value
—
Callahan Jennifer L.
SVP and CFO
Date
Feb 6
Shares
4,864
Price
$5.04
Value
$25K
Schaffer Shane J.
CEO · Director
Date
Feb 6
Shares
6,809
Price
$5.04
Value
$34K
Brams Matthew
EVP and Chief Medical Officer
Date
Feb 6
Shares
1,946
Price
$5.04
Value
$10K
Callahan Jennifer L.
Corporate Controller
Date
Sep 15
Shares
5,000
Price
$0.67
Value
$3K
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About CING insider trading
CING insider trades
Cingulate Inc. (CING) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Schaffer Shane J. (CEO · Director), Callahan Jennifer L. (EVP and CFO), Brams Matthew (EVP and Chief Medical Officer). Over the past 12 months, 5 insiders have filed transactions with the SEC. CING insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Cingulate Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
CING insider trading · 5 questionsThe insiders of Cingulate Inc. (CING) include executives and directors such as Schaffer Shane J. (CEO · Director), Callahan Jennifer L. (EVP and CFO), Brams Matthew (EVP and Chief Medical Officer), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026